Mesacast Pesquisa Clínica | O Brasil na Pesquisa Clínica | Com Dr. Stephen Stefani

In this episode of the Clinical Research Mesacast, oncologist and health economics specialist Dr. Stephen Stefani and Juliana Mauri, executive manager of clinical research at the Instituto Vencer o Câncer (Cancer Victory Institute), discuss Brazil's place in the global landscape of clinical trials. Brazil accounts for approximately 2% of clinical trials worldwide and ranks 20th globally. This number does not reflect the size of the country, its diverse population, and the existing infrastructure. What is holding us back, what is changing, and what is the direct impact of this on patients' lives? 🔍 What you will find in this episode: • What the data says about Brazil in global clinical research and how to interpret this scenario • The new law on clinical research in humans: advances and challenges in implementation • The main bottlenecks, regulation, infrastructure and investment • The role of the pharmaceutical industry and the public sector in financing studies • Brazil's potential and what needs to happen for it to stop being just a projection Dr. Stephen Stefani is an oncologist, researcher and specialist in health economics, working at the Americas Health Foundation. This episode is a production of the Instituto Vencer o Câncer and the Rede Vencer o Câncer de Pesquisa Clínica, with a commitment to strengthening the clinical research ecosystem in Brazil and expanding patient access to innovative treatments. 📌 Subscribe to the channel, activate notifications and share this content with those who work in or are interested in the topic. The Rede Vencer o Câncer de Pesquisa Clínica program is supported by AstraZeneca, Fundação Brava, RD Saúde and Roche. #PublicHealth #CancerInBrazil